Table 2.

The mean parasite load (lesion) of the different studied groups at the end of treatment and 1 month later

	Group I		Group II	Group IIIa	Group IIIb	p
	C1	C2
End of treatment	107 (106–107)	107 (107–107)	103 (102–104)	101 (101–102)	104 (103–105)	<0.001*
Sig. with			C2***	C2***,II***	C1***, IIIa***
1 month post treatment	–	–	102 (101–103)	101 (101–102)	106 (105–106)	0.002*
Sig. with				II**	II***, IIIa***

Data were described using median, minimum and maximum

C1 control infected non treated group corresponding to group IIIb, C2 control infected non treated group corresponding to group II and group IIIa; Group II: infected treated mice with miltefosine for 20 days; Group IIIa: infected treated mice with azithromycin for 20 days; Group IIIb: infected treated mice with combination of miltefosine and azithromycin for 10 days. * Significant at P < 0.05; ** significant at P < 0.01; *** significant at P < 0.001